Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chowdari V. Kodavali"'
Autor:
Susana M. Beltrán, Justin Bobo, Ahmed Habib, Chowdari V. Kodavali, Lincoln Edwards, Priyadarshini Mamindla, Rebecca E. Taylor, Philip R. LeDuc, Pascal O. Zinn
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract The ability to model physiological systems through 3D neural in-vitro systems may enable new treatments for various diseases while lowering the need for challenging animal and human testing. Creating such an environment, and even more impact
Externí odkaz:
https://doaj.org/article/ae28db549b3f49a3a8976bb560015074
Autor:
Sanjay K. Singh, Yan Wang, Ahmed Habib, Mamindla Priyadarshini, Chowdari V. Kodavali, Apeng Chen, Wencai Ma, Jing Wang, N. U. Farrukh Hameed, Baoli Hu, Gregory N. Fuller, Scott M. Kulich, Nduka Amankulor, Rivka R. Colen, Lincoln A. Edwards, Pascal O. Zinn
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Glioblastoma (GBM) is fatal and the study of therapeutic resistance, disease progression, and drug discovery in GBM or glioma stem cells is often hindered by limited resources. This limitation slows down progress in both drug discovery and patient su
Externí odkaz:
https://doaj.org/article/14b70cbfdcae49adb6619b89be2df058
Autor:
Susana M. Beltrán, Justin Bobo, Ahmed Habib, Chowdari V. Kodavali, Lincoln Edwards, Priyadarshini Mamindla, Rebecca E. Taylor, Philip R. LeDuc, Pascal O. Zinn
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/9d755f9b39d2466f8a64a73945c5ae48
Autor:
Jamison Beiriger, Ahmed Habib, Nicolina Jovanovich, Chowdari V. Kodavali, Lincoln Edwards, Nduka Amankulor, Pascal O. Zinn
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Glioblastoma (GBM) is a malignant tumor with a median survival rate of 15-16 months with standard care; however, cases of successful treatment offer hope that an enhanced understanding of the pathology will improve the prognosis. The cell of origin i
Externí odkaz:
https://doaj.org/article/d54c18cc0db0453d927cb058ec2c6e40
Autor:
Jamison Beiriger, Ahmed Habib, Nicolina Jovanovich, Chowdari V. Kodavali, Lincoln Edwards, Nduka Amankulor, Pascal O. Zinn
Publikováno v:
Frontiers in oncology. 12
Glioblastoma (GBM) is a malignant tumor with a median survival rate of 15-16 months with standard care; however, cases of successful treatment offer hope that an enhanced understanding of the pathology will improve the prognosis. The cell of origin i